Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Saeed, Sahar"" wg kryterium: Autor


Tytuł:
HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Autorzy:
Vali B; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Jones RB
Sakhdari A
Sheth PM
Clayton K
Yue FY
Gyenes G
Wong D
Klein MB
Saeed S
Benko E
Kovacs C
Kaul R
Ostrowski MA
Pokaż więcej
Źródło:
European journal of immunology [Eur J Immunol] 2010 Sep; Vol. 40 (9), pp. 2493-505.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, CD/*metabolism
Apoptosis Regulatory Proteins/*metabolism
CD8-Positive T-Lymphocytes/*metabolism
HIV Infections/*immunology
HIV-1/*immunology
Hepacivirus/*immunology
Hepatitis C/*immunology
Membrane Proteins/*metabolism
Antibodies, Blocking/pharmacology ; Antigens, CD/genetics ; Antigens, CD/immunology ; Antigens, Viral/immunology ; Apoptosis Regulatory Proteins/genetics ; Apoptosis Regulatory Proteins/immunology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; CD8-Positive T-Lymphocytes/virology ; Cell Proliferation/drug effects ; Cell Separation ; Cells, Cultured ; Disease Progression ; Female ; Flow Cytometry ; HIV Infections/complications ; HIV Infections/pathology ; HIV Infections/physiopathology ; HIV-1/pathogenicity ; HLA-A Antigens/immunology ; HLA-A Antigens/metabolism ; HLA-A2 Antigen ; Hepacivirus/pathogenicity ; Hepatitis A Virus Cellular Receptor 2 ; Hepatitis C/complications ; Hepatitis C/pathology ; Hepatitis C/physiopathology ; Humans ; Liver/immunology ; Liver/pathology ; Liver/virology ; Male ; Membrane Proteins/genetics ; Membrane Proteins/immunology ; Programmed Cell Death 1 Receptor
Czasopismo naukowe
Tytuł:
Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.
Autorzy:
Cox J; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec, Canada H3A 1A2; Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, Quebec, Canada H2X 2P4; Public Health Department, Montreal Health and Social Services Agency, 1301 Sherbrooke Street East, Montreal, Quebec, Canada H2L 1M3; CIHR Canadian HIV Trials Network, 588-1081 Burrard Street, Vancouver, British Columbia, Canada V6B 3E6. Electronic address: .
Maurais E; Public Health Department, Montreal Health and Social Services Agency, 1301 Sherbrooke Street East, Montreal, Quebec, Canada H2L 1M3.
Hu L; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec, Canada H3A 1A2.
Moodie EE; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec, Canada H3A 1A2.
Law S; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec, Canada H3A 1A2.
Bozinoff N; Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, Quebec, Canada H2X 2P4.
Potter M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec, Canada H3A 1A2; Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, Quebec, Canada H2X 2P4.
Rollet K; Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, Quebec, Canada H2X 2P4.
Hull M; CIHR Canadian HIV Trials Network, 588-1081 Burrard Street, Vancouver, British Columbia, Canada V6B 3E6; BC Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6.
Tyndall M; CIHR Canadian HIV Trials Network, 588-1081 Burrard Street, Vancouver, British Columbia, Canada V6B 3E6; Department of Medicine, Infectious Diseases Division, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6.
Cooper C; CIHR Canadian HIV Trials Network, 588-1081 Burrard Street, Vancouver, British Columbia, Canada V6B 3E6; Department of Medicine, Infectious Diseases Division, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, Canada K1H 8L6.
Gill J; CIHR Canadian HIV Trials Network, 588-1081 Burrard Street, Vancouver, British Columbia, Canada V6B 3E6; Southern Alberta HIV Clinic, 1213 4 Street SW, Calgary, Alberta, Canada T2R 0X7.
Saeed S; Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, Quebec, Canada H2X 2P4.
Klein MB; Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, Quebec, Canada H2X 2P4; CIHR Canadian HIV Trials Network, 588-1081 Burrard Street, Vancouver, British Columbia, Canada V6B 3E6.
Pokaż więcej
Corporate Authors:
Canadian Co-infection Cohort (CTN 222)
Źródło:
Drug and alcohol dependence [Drug Alcohol Depend] 2014 Apr 01; Vol. 137, pp. 121-8. Date of Electronic Publication: 2014 Jan 30.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Patient Compliance*
Coinfection/*epidemiology
HIV Infections/*epidemiology
Hepatitis C/*epidemiology
Substance Abuse Treatment Centers/*trends
Substance-Related Disorders/*epidemiology
Adult ; Canada/epidemiology ; Cohort Studies ; Coinfection/therapy ; Female ; Follow-Up Studies ; HIV Infections/therapy ; Hepatitis C/therapy ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Substance-Related Disorders/therapy
Czasopismo naukowe
Tytuł:
Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.
Autorzy:
Sagan SM; Department of Microbiology & Immunology, McGill University, Montréal, QC, Canada H3A 2B4.
Dupont B; Liver Unit, Department of Medicine, Université de Montréal, Montréal, QC, Canada H3T 1J4.
Grebely J; The Kirby Institute, UNSW Australia, Sydney, NSW 2052, Australia.
Krajden M; British Columbia Centre for Disease Control, Vancouver, BC, Canada V5Z 4R4; University of British Columbia, Vancouver, BC, Canada V6T 1Z4.
MacParland SA; Toronto General Research Institute, University Health Network, Toronto, ON, Canada M5G 1L7.
Raven JF; Canadian Institutes of Health Research-Institute of Infection and Immunity, Ottawa, ON, Canada K1A 0W9.
Saeed S; Department of Epidemiology, McGill University, Montréal, QC, Canada H3A 1A2.
Feld JJ; Toronto Western Hospital Liver Center, University Health Network, Toronto, ON, Canada M5T 2S8.
Tyrrell DL; Li Ka Shing Institute of Virology, Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, AB, Canada T6G 2E1.
Wilson JA; Department of Microbiology & Immunology, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5.
Pokaż więcej
Źródło:
Canadian journal of gastroenterology & hepatology [Can J Gastroenterol Hepatol] 2016; Vol. 2016, pp. 5743521. Date of Electronic Publication: 2016 Apr 27.
Typ publikacji:
Congress
MeSH Terms:
Health Policy*
Hepatitis C*
Antiviral Agents/therapeutic use ; Canada ; Cost of Illness ; Humans
Tytuł:
The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.
Autorzy:
van Buuren N; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Fradette L; Centre de Recherche du Centre Hospitalier Universitaire de Montréal (CHUM), Montreal, QC, Canada.
Grebely J; The Kirby Institute, UNSW, Sydney, NSW 2052, Australia.
King A; Simon Fraser University, Burnaby, BC, Canada.
Krajden M; British Columbia Centre for Disease Control, Vancouver, BC, Canada V5Z 4R4; University of British Columbia, Vancouver, BC, Canada V6T 1Z4.
MacParland SA; Multi-Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.
Marshall A; The Kirby Institute, UNSW, Sydney, NSW 2052, Australia.
Saeed S; Chronic Viral Illnesses Service, Division of Infectious Diseases and Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Wilson J; Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK, Canada.
Klein MB; Chronic Viral Illnesses Service, Division of Infectious Diseases and Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Sagan SM; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada H3A 2B4.
Pokaż więcej
Źródło:
Canadian journal of gastroenterology & hepatology [Can J Gastroenterol Hepatol] 2016; Vol. 2016, pp. 7603526. Date of Electronic Publication: 2016 Oct 24.
Typ publikacji:
Congress
MeSH Terms:
Hepacivirus*
Hepatitis C*
Antiviral Agents/*therapeutic use
Canada/epidemiology ; Humans
Tytuł:
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.
Autorzy:
Marshall, Alison D.
Saeed, Sahar
Barrett, Lisa
Cooper, Curtis L.
Treloar, Carla
Bruneau, Julie
Feld, Jordan J.
Gallagher, Lesley
Klein, Marina B.
Krajden, Mel
Shoukry, Naglaa H.
Taylor, Lynn E.
Grebely, Jason
Pokaż więcej
Źródło:
CMAJ Open. Oct2016, Vol. 4 Issue 4, pE605-E614. 10p.
Czasopismo naukowe
Tytuł:
A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
Autorzy:
Moqueet N; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.
Kanagaratham C; Department of Medicine and Department of Human Genetics, McGill University, Montreal, QC, Canada.
Gill MJ; Southern Alberta HIV Clinic, Calgary, Alberta, Canada.
Hull M; BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada.
Walmsley S; Toronto General Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada.
Radzioch D; Department of Medicine and Department of Human Genetics, McGill University, Montreal, QC, Canada.
Saeed S; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.
Platt RW; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.
Klein MB; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.
Pokaż więcej
Corporate Authors:
Canadian Co-infection Cohort Study (CTN 222)
Źródło:
PloS one [PLoS One] 2017 May 03; Vol. 12 (5), pp. e0176282. Date of Electronic Publication: 2017 May 03 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Models, Biological*
HIV Infections/*complications
Hepatitis C/*complications
Liver Cirrhosis/*pathology
Adult ; Canada ; Cohort Studies ; Female ; Humans ; Liver Cirrhosis/complications ; Male ; Middle Aged ; Prognosis ; Prospective Studies
Czasopismo naukowe
Tytuł:
Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Autorzy:
Saeed S; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Division of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Glen site, McGill University Health Centre, Montreal, QC, Canada.
Strumpf EC; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Department of Economics, McGill University, Montreal, QC, Canada.
Moodie EE; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.
Young J; Division of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Glen site, McGill University Health Centre, Montreal, QC, Canada.
Nitulescu R; Division of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Glen site, McGill University Health Centre, Montreal, QC, Canada.
Cox J; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Division of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Glen site, McGill University Health Centre, Montreal, QC, Canada.
Wong A; Regina Qu'Appelle Health Region, Regina, SK, Canada.
Walmsely S; University Health Network, Toronto, ON, Canada.; CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Cooper C; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Vachon ML; Centre Hospitalier de l'Université Laval, Quebec, QC, Canada.
Martel-Laferriere V; Centre de Recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Hull M; Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada.
Conway B; Vancouver Infectious Diseases Centre, Vancouver, BC, Canada.
Klein MB; Division of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Glen site, McGill University Health Centre, Montreal, QC, Canada.; CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.
Pokaż więcej
Corporate Authors:
Canadian Co-Infection Cohort Study
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2017 Nov; Vol. 20 (3).
Typ publikacji:
Journal Article
MeSH Terms:
Early Medical Intervention*
Patient Acceptance of Health Care*
Antiviral Agents/*therapeutic use
HIV Infections/*drug therapy
Hepatitis C/*complications
Adult ; Canada ; Cohort Studies ; Coinfection/drug therapy ; Female ; HIV Infections/complications ; Hepacivirus ; Hepatitis C/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Substance Abuse, Intravenous/complications
Czasopismo naukowe
Tytuł:
Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.
Autorzy:
Sacks-Davis R; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Medicine, The University of Melbourne, Melbourne, Australia.
Doyle JS; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Infectious Diseases, The Alfred and Monash University, Melbourne, Australia.
Rauch A; Department of Infectious Diseases, University Hospital and University of Bern, Bern, Switzerland.
Beguelin C; Department of Infectious Diseases, University Hospital and University of Bern, Bern, Switzerland.
Pedrana AE; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Matthews GV; The Kirby Institute, University of New South Wales, Sydney, Australia.
Prins M; Public Health Service Amsterdam, Amsterdam, the Netherlands.
van der Valk M; International Antiviral Therapy Evaluation Center and Department of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, Amsterdam, the Netherlands.
Klein MB; Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada.
Saeed S; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Lacombe K; Infectious Diseases, AP-HP, Sorbonne Universités and Inserm UMR-S1136, Paris, France.
Chkhartishvili N; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
Altice FL; Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA.; Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Centre of Excellence in Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia.
Hellard ME; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Pokaż więcej
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2018 Apr; Vol. 21 Suppl 2, pp. e25051.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
HIV Infections/*drug therapy
Hepatitis C/*drug therapy
Antiviral Agents/administration & dosage ; Coinfection ; Continuity of Patient Care ; Delivery of Health Care ; Disease Eradication ; HIV Infections/complications ; HIV Infections/epidemiology ; Hepatitis C/complications ; Hepatitis C/epidemiology ; Humans
Czasopismo naukowe
Tytuł:
Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.
Autorzy:
Golizeh M; Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Melendez-Pena CE; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Ward BJ; Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Saeed S; Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Santamaria C; Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Conway B; Vancouver Infectious Diseases Center, Vancouver, British Columbia, Canada.
Cooper C; The Ottawa Hospital-General Campus, Ottawa, Ontario, Canada.
Klein MB; Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Ndao M; Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.; National Reference Centre for Parasitology, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Pokaż więcej
Corporate Authors:
Canadian Co-Infection Cohort (CTN222)
Źródło:
PloS one [PLoS One] 2018 Apr 02; Vol. 13 (4), pp. e0195148. Date of Electronic Publication: 2018 Apr 02 (Print Publication: 2018).
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Coinfection*
Proteome*
Proteomics*/methods
HIV Infections/*blood
HIV Infections/*complications
Hepatitis C/*blood
Hepatitis C/*complications
Liver Cirrhosis/*diagnosis
Liver Cirrhosis/*etiology
Biomarkers ; Canada ; Clinical Decision-Making ; Decision Trees ; Humans ; ROC Curve ; Severity of Illness Index ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Czasopismo naukowe
Tytuł:
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals.
Autorzy:
Saeed S; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.; Division of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Glen Site, McGill University Health Centre, Montreal, Quebec, Canada.
Moodie EEM; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Strumpf E; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.; Department of Economics, McGill University, Montreal, Quebec, Canada.
Gill J; Southern Alberta HIV Clinic, Calgary, Alberta, Canada.
Wong A; Regina Qu'Appelle Health Region, Regina, Saskatchewan, Canada.
Cooper C; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Walmsley S; University Health Network, Toronto, Ontario, Canada.; CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada.
Hull M; Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Martel-Laferriere V; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Klein MB; Division of Infectious Diseases/Chronic Viral Illness Service, Department of Medicine, Glen Site, McGill University Health Centre, Montreal, Quebec, Canada.; CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada.
Pokaż więcej
Corporate Authors:
Canadian Co-Infection Cohort Study Investigators
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2018 Dec; Vol. 25 (12), pp. 1507-1514. Date of Electronic Publication: 2018 Sep 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*administration & dosage
HIV Infections/*complications
Hepatitis C, Chronic/*drug therapy
Quality of Life/*psychology
Administration, Oral ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Surveys and Questionnaires ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals.
Autorzy:
Nitulescu R; Department of Medicine, Division of Infectious Diseases/Chronic Viral Illness Service, Glen site, McGill University Health Centre, Montreal, Canada.
Young J; Department of Medicine, Division of Infectious Diseases/Chronic Viral Illness Service, Glen site, McGill University Health Centre, Montreal, Canada; Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Switzerland; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
Saeed S; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
Cooper C; Department of Medicine, University of Ottawa, Ottawa, Canada.
Cox J; Department of Medicine, Division of Infectious Diseases/Chronic Viral Illness Service, Glen site, McGill University Health Centre, Montreal, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
Martel-Laferriere V; Centre hospitalier de l'Université de Montréal, Montreal, Canada.
Hull M; Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, Canada.
Walmsley S; University Health Network, Toronto, Canada; CIHR Canadian HIV Trials Network, Vancouver, Canada.
Tyndall M; University of British Columbia, Vancouver, Canada.
Wong A; Department of Medicine, University of Saskatchewan, Regina, Canada.
Klein MB; Department of Medicine, Division of Infectious Diseases/Chronic Viral Illness Service, Glen site, McGill University Health Centre, Montreal, Canada; CIHR Canadian HIV Trials Network, Vancouver, Canada. Electronic address: .
Pokaż więcej
Corporate Authors:
Canadian Co-Infection Cohort Study
Źródło:
The International journal on drug policy [Int J Drug Policy] 2019 Mar; Vol. 65, pp. 41-49. Date of Electronic Publication: 2018 Dec 26.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
Coinfection/*drug therapy
Hepatitis C, Chronic/*drug therapy
Substance Abuse Treatment Centers/*statistics & numerical data
Adult ; Canada ; Cohort Studies ; Drug Users ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Hepatitis C, Chronic/complications ; Hepatitis C, Chronic/epidemiology ; Humans ; Liver Cirrhosis ; Male ; Middle Aged ; Prospective Studies ; Public Health/legislation & jurisprudence ; Substance Abuse, Intravenous
Czasopismo naukowe
Tytuł:
Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs.
Autorzy:
Latham NH; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; School of Medicine, Monash University, Melbourne, Australia.
Doyle JS; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Australia.
Palmer AY; Disease Elimination Program, Burnet Institute, Melbourne, Australia.
Vanhommerig JW; Disease Elimination Program, Burnet Institute, Melbourne, Australia.
Agius P; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Goutzamanis S; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Li Z; Disease Elimination Program, Burnet Institute, Melbourne, Australia.
Pedrana A; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Gottfredsson M; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Division of Infectious Diseases, Landspitali University Hospital, Reykjavik, Iceland.; Department of Science, Landspitali University Hospital, Reykjavik, Iceland.
Bouscaillou J; Médecins du Monde, Paris, France.
Luhmann N; Médecins du Monde, Paris, France.
Mazhnaya A; The International Charitable Foundation Alliance for Public Health, Kyiv, Ukraine.; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore.
Altice FL; Section of Infectious Diseases, Yale University School of Medicine, New Haven.; Division of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven.
Saeed S; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Klein M; Department of Medicine, McGill University Health Centre, Montreal, Canada.
Falade-Nwulia OO; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore.
Aspinall E; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, United Kingdom.; Health Protection Scotland, National Services Scotland, Glasgow, United Kingdom.
Hutchinson S; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, United Kingdom.; Health Protection Scotland, National Services Scotland, Glasgow, United Kingdom.
Hellard ME; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.; Doherty Institute, University of Melbourne, Melbourne, Australia.
Sacks-Davis R; Disease Elimination Program, Burnet Institute, Melbourne, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Medicine, University of Melbourne, Australia.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2019 Dec; Vol. 39 (12), pp. 2244-2260. Date of Electronic Publication: 2019 Jun 10.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Drug Users*
Antiviral Agents/*therapeutic use
Hepatitis C/*drug therapy
Humans ; Medication Adherence ; Opiate Substitution Treatment ; Sustained Virologic Response
Czasopismo naukowe
Tytuł:
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Autorzy:
Saeed S; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
Drews SJ; Microbiology Department, Canadian Blood Services, Ottawa, Ontario, Canada.; Department of Laboratory Medicine & Pathology, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, Alberta, Canada.
Pambrun C; Center for Innovation, Canadian Blood Services, Ottawa, Ontario, Canada.; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Yi QL; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Osmond L; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.
O'Brien SF; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
Transfusion [Transfusion] 2021 Mar; Vol. 61 (3), pp. 862-872. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Serological Testing*
Blood Donors/*statistics & numerical data
COVID-19/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Viral/blood ; Biomarkers/blood ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/immunology ; Canada/epidemiology ; Cross-Sectional Studies ; Female ; Humans ; Immunoglobulin G/blood ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Pandemics ; Prevalence ; SARS-CoV-2/immunology ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł:
Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada.
Autorzy:
Palayew A; Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada.
Schmidt AM; Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada.
Saeed S; Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada.
Cooper CL; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, British Columbia, Canada.
Wong A; Department of Medicine, University of Saskatchewan, Regina, Saskatchewan, Canada.
Martel-Laferrière V; Department of Microbiology and Infectious Diseases, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Walmsley S; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, British Columbia, Canada.; University Health Network, University of Toronto, Toronto, Canada.
Cox J; Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada.; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, British Columbia, Canada.; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Klein MB; Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Quebec, Canada.; Canadian Institutes of Health Research, Canadian HIV Trials Network, Vancouver, British Columbia, Canada.; Division of Infectious Diseases and Chronic Viral Illness Service, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Pokaż więcej
Corporate Authors:
Canadian Coinfection Cohort Study Investigators
Źródło:
PloS one [PLoS One] 2021 Apr 19; Vol. 16 (4), pp. e0249836. Date of Electronic Publication: 2021 Apr 19 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Psychosocial Deprivation*
Coinfection/*psychology
HIV Infections/*psychology
Hepatitis C/*psychology
Canada ; Coinfection/epidemiology ; Female ; HIV Infections/complications ; HIV Infections/epidemiology ; Hepatitis C/complications ; Hepatitis C/epidemiology ; Humans ; Life Style ; Male ; Middle Aged ; Socioeconomic Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies